CA2363119A1 - Hemocompatible surfaces and method for producing same - Google Patents

Hemocompatible surfaces and method for producing same Download PDF

Info

Publication number
CA2363119A1
CA2363119A1 CA002363119A CA2363119A CA2363119A1 CA 2363119 A1 CA2363119 A1 CA 2363119A1 CA 002363119 A CA002363119 A CA 002363119A CA 2363119 A CA2363119 A CA 2363119A CA 2363119 A1 CA2363119 A1 CA 2363119A1
Authority
CA
Canada
Prior art keywords
hemocompatible
producing same
hemocompatible surfaces
present
fields
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002363119A
Other languages
French (fr)
Other versions
CA2363119C (en
Inventor
Michael Hoffmann
Roland Horres
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2363119A1 publication Critical patent/CA2363119A1/en
Application granted granted Critical
Publication of CA2363119C publication Critical patent/CA2363119C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
    • A61L33/06—Use of macromolecular materials
    • A61L33/12—Polypeptides, proteins or derivatives thereof, e.g. degradation products thereof
    • A61L33/128—Other specific proteins or polypeptides not covered by A61L33/122 - A61L33/126
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
    • A61L33/06—Use of macromolecular materials
    • A61L33/08—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
    • A61L33/18—Use of ingredients of undetermined constitution or reaction products thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Surgery (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)
  • Saccharide Compounds (AREA)
  • Dental Preparations (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention concerns hemocompatible surfaces characterized in that they contain materials, and constituents of the outer layers of blood cells and/or mesothelial cells are applied and/or incorporated onto and/or into the surfaces of said materials. The present invention further concerns a process for making hemocompatible surfaces and their use in extensive fields of health, in medicine, dentistry, surgery, cosmetics or in fields having contact with blood, tissue and/or other body fluids.
CA002363119A 1999-02-26 2000-02-24 Hemocompatible surfaces and method for producing same Expired - Fee Related CA2363119C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19908318.5 1999-02-26
DE19908318A DE19908318A1 (en) 1999-02-26 1999-02-26 Hemocompatible surfaces and methods of making them
PCT/EP2000/001497 WO2000050106A2 (en) 1999-02-26 2000-02-24 Hemocompatible surfaces and method for producing same

Publications (2)

Publication Number Publication Date
CA2363119A1 true CA2363119A1 (en) 2000-08-31
CA2363119C CA2363119C (en) 2007-04-10

Family

ID=7898933

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002363119A Expired - Fee Related CA2363119C (en) 1999-02-26 2000-02-24 Hemocompatible surfaces and method for producing same

Country Status (12)

Country Link
EP (1) EP1152778B1 (en)
JP (1) JP3597474B2 (en)
KR (1) KR100503913B1 (en)
CN (1) CN1198660C (en)
AT (1) ATE250437T1 (en)
AU (1) AU758873B2 (en)
BR (1) BR0008968A (en)
CA (1) CA2363119C (en)
DE (2) DE19908318A1 (en)
IL (1) IL144912A (en)
WO (1) WO2000050106A2 (en)
ZA (1) ZA200106738B (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8679520B2 (en) 2001-10-15 2014-03-25 Hemoteq Ag Coating of stents for preventing restenosis
US8784862B2 (en) 2002-05-09 2014-07-22 Hemoteq Ag Compounds and method for coating surfaces in a hemocompatible manner
US10080821B2 (en) 2009-07-17 2018-09-25 Boston Scientific Scimed, Inc. Nucleation of drug delivery balloons to provide improved crystal size and density
US10369256B2 (en) 2009-07-10 2019-08-06 Boston Scientific Scimed, Inc. Use of nanocrystals for drug delivery from a balloon

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10329296B4 (en) * 2003-06-24 2007-07-12 Leibniz-Institut Für Polymerforschung Dresden E.V. Coating system for biomaterials
DE102005040211B4 (en) 2005-08-16 2010-02-11 Maquet Cardiopulmonary Ag Use of nonionic esters in a coating for blood contacting surfaces and medical device
MX354144B (en) 2006-07-03 2018-02-14 Hemoteq Ag Manufacture, method, and use of active substance-releasing medical products for permanently keeping blood vessels open.
US8597720B2 (en) 2007-01-21 2013-12-03 Hemoteq Ag Medical product for treating stenosis of body passages and for preventing threatening restenosis
US9192697B2 (en) 2007-07-03 2015-11-24 Hemoteq Ag Balloon catheter for treating stenosis of body passages and for preventing threatening restenosis
US8889211B2 (en) 2010-09-02 2014-11-18 Boston Scientific Scimed, Inc. Coating process for drug delivery balloons using heat-induced rewrap memory
WO2013022458A1 (en) 2011-08-05 2013-02-14 Boston Scientific Scimed, Inc. Methods of converting amorphous drug substance into crystalline form
WO2013028208A1 (en) 2011-08-25 2013-02-28 Boston Scientific Scimed, Inc. Medical device with crystalline drug coating
CN102501344B (en) * 2011-09-29 2014-07-16 华东交通大学 Method for constructing hemocompatible material surface with bionic periodic structure
KR102223440B1 (en) * 2013-02-08 2021-03-05 아셀, 인크. Methods of manufacturing bioactive gels from extracellular matrix material

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4350629A (en) * 1981-07-29 1982-09-21 Massachusetts Institute Of Technology Procedures for preparing composite materials from collagen and glycosaminoglycan
DE3639561A1 (en) * 1986-11-20 1988-06-01 Baumann Hanno METHOD FOR PRODUCING NON-THROMBOGEN SUBSTRATES
US5236835A (en) * 1988-10-05 1993-08-17 Hapgood, C.V. Electro insertion of proteins into red cell membranes
US5043164A (en) * 1989-01-17 1991-08-27 The University Of Tennessee Research Corporation Blood-stable, cholesterol-free liposomes
GB9116036D0 (en) * 1991-07-25 1991-09-11 Univ Leicester Preparing grafts for implantation
DE4402064A1 (en) * 1994-01-25 1995-07-27 Kohlensaeurewerk Deutschland Process for controlling pests in bulk material
US5643712A (en) * 1994-05-20 1997-07-01 Brasile; Lauren Method for treating and rendering grafts nonthrombogenic and substantially nonimmunogenic using an extracellular matrix coating
DE19505070C2 (en) * 1995-02-15 1997-03-27 Axel Prof Dr Med Haverich Artificial vascular systems and processes for their manufacture
DE19648876C2 (en) * 1996-11-16 1999-10-07 Will Minuth Method of making a natural implant
DE19700078A1 (en) * 1997-01-03 1998-07-09 Huels Chemische Werke Ag Production of polymeric materials with cell proliferation-promoting properties
DE19706667A1 (en) * 1997-02-20 1998-08-27 Merck Patent Gmbh Bone replacement material with a surface covering with peptides with RGD amino acid sequence
DE19724869C2 (en) * 1997-06-12 1999-05-12 Henkel Kgaa Use of citosan derivatives for surface coating

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8679520B2 (en) 2001-10-15 2014-03-25 Hemoteq Ag Coating of stents for preventing restenosis
US8784862B2 (en) 2002-05-09 2014-07-22 Hemoteq Ag Compounds and method for coating surfaces in a hemocompatible manner
US10369256B2 (en) 2009-07-10 2019-08-06 Boston Scientific Scimed, Inc. Use of nanocrystals for drug delivery from a balloon
US11278648B2 (en) 2009-07-10 2022-03-22 Boston Scientific Scimed, Inc. Use of nanocrystals for drug delivery from a balloon
US10080821B2 (en) 2009-07-17 2018-09-25 Boston Scientific Scimed, Inc. Nucleation of drug delivery balloons to provide improved crystal size and density

Also Published As

Publication number Publication date
KR100503913B1 (en) 2005-07-26
DE50003828D1 (en) 2003-10-30
JP2002537075A (en) 2002-11-05
JP3597474B2 (en) 2004-12-08
ZA200106738B (en) 2002-08-15
CA2363119C (en) 2007-04-10
DE19908318A1 (en) 2000-08-31
IL144912A (en) 2009-09-22
IL144912A0 (en) 2002-06-30
CN1341033A (en) 2002-03-20
CN1198660C (en) 2005-04-27
AU758873B2 (en) 2003-04-03
AU4287100A (en) 2000-09-14
WO2000050106A3 (en) 2001-04-26
BR0008968A (en) 2001-11-27
KR20010104343A (en) 2001-11-24
EP1152778B1 (en) 2003-09-24
WO2000050106A2 (en) 2000-08-31
EP1152778A1 (en) 2001-11-14
ATE250437T1 (en) 2003-10-15

Similar Documents

Publication Publication Date Title
CA2363119A1 (en) Hemocompatible surfaces and method for producing same
CA2140090A1 (en) Composite bioabsorbable materials and surgical articles made therefrom
AU775126C (en) Substituted oxazolidinones and their use in the field of blood coagulation
AU2676795A (en) Soft implantable surgical prosthesis for increasing or restoring the volume of soft tissues, in particular a breast prosthesis and method of manufacture
EP0951914A3 (en) Medical adhesive
GB9925804D0 (en) Biological materials and method useful in the diagnosis and treatment of diseases
CA2173316A1 (en) Local polymeric gel cellular therapy
WO2005034763A8 (en) Devices, systems, and methods for suturing tissue
PL321781A1 (en) Method of coating objects with hialuronic acid, its derivatives and semi-synthetic polymers
CA2212058A1 (en) Preparation and use of a specific gaba-a.alpha.5 receptor ligand for treatment of alzheimer's disease
CA2350713A1 (en) Use of biochemical substances for a composition for the prevention and treatment of health conditions caused by constriction of smooth muscle cells in organs of the human body
AU2002220577A1 (en) Circulatory device for separating substances in bodily fluids, especially blood,and the use of said device
ZA977494B (en) Phenyl-substituted alkenylcarboxylic acid guanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them.
AU2001250978A1 (en) Polynucleotides and polypeptides, their use in diagnosis and treatment of cardiac, renal or inflammary disease
AU1873599A (en) Stent for implantation in the human body, especially in blood vessels
EE200300504A (en) Preparations of 3,7-diazabicyclo [3.3.1], methods for their preparation and their use in the prophylaxis or treatment of cardiac arrhythmias
HUP0302538A3 (en) 3,7-diazabicyclo[3.3.0]oczanes and their use in the treatment of cardiac arrhythmias, process for their preparation and pharmaceutical compositions containing them
CA2279497A1 (en) The use of levobupivacaine in facial surgery
HUP9802897A3 (en) Optically active pyridyl-4h-1,2,4-oxadiazine derivatives, the use thereof in the treatment of vascular diseases and pharmaceutical composition containing the compound as active ingredient
AU3382089A (en) Uncrosslinked hydrogel, process for its preparation and its uses as an article for medical and/or surgical purposes such as tubes, filaments, films, joints, implants and the like, particularly in ophthalmology
AU2002322301A1 (en) Methods for the diagnosis and treatment of cardiac tissue rejection
AU2001296173A1 (en) 3,8-diazabicyclo(3.2.1)octanes and their use in the treatment of cardiac arrhythmias
CA2376033A1 (en) Use of l-carnitine and its alkanoyl derivatives for the preparation of a medicament useful for the treatment of patients suffering from diabetic and/or dysmetabolic nephropathy
EE200300506A (en) Preparations of 3,7-diazabicyclo [3.3.1], methods for their preparation and their use in the prophylaxis or treatment of cardiac arrhythmias
AU2001289930A1 (en) Method for the production of human antibodies, antibodies thus obtained and their use in therapy and diagnosis

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed